Apogee Therapeutics, Inc. APGE Issuance of common stock for the acquisition of Ansys
Issuance of common stock for the acquisition of Ansys at other companies
Other financials
Where this comes from
Reported directly by Apogee Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:StockIssued1.
The official record: Apogee Therapeutics, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Apogee Therapeutics, Inc.'s issuance of common stock for the acquisition of ansys.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Apogee Therapeutics, Inc.'s issuance of common stock for the acquisition of ansys?
- Apogee Therapeutics, Inc. (APGE) reported issuance of common stock for the acquisition of ansys of $256K in Q1 2026.